News & Events

News & Events

Press Releases

January 12, 2026
Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome
January 08, 2026
Encoded Therapeutics Highlights Progress in Dravet Syndrome Program and Pipeline Ahead of Company Presentation at 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
Encoded Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026
View All Press Releases

Media Kit

Logo

Media Kit - Logos

Leadership Photos

Kartik Ramamoorthi, Ph.D.
Kartik Ramamoorthi, Ph.D.
Encoded Co-Founder, CEO and Board Member
Stephanie Tagliatela
Stephanie Tagliatela
Encoded Co-Founder, Chief Scientific Officer and Board Member
Salvador Rico, M.D., Ph.D.
Salvador Rico, M.D., Ph.D.
Encoded Chief Medical Officer

Photos

Encoded lab coat
Encoded lab coat
Encoded Therapeutics headquarters in South San Francisco
Encoded Therapeutics headquarters in South San Francisco
Scientists in Encoded’s sequencing lab
Scientists in Encoded’s sequencing lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Download Photo Archive

Video Footage

Media Kit - Footage